NO982582L - Fremgangsmaate for behandling av smerte - Google Patents

Fremgangsmaate for behandling av smerte

Info

Publication number
NO982582L
NO982582L NO982582A NO982582A NO982582L NO 982582 L NO982582 L NO 982582L NO 982582 A NO982582 A NO 982582A NO 982582 A NO982582 A NO 982582A NO 982582 L NO982582 L NO 982582L
Authority
NO
Norway
Prior art keywords
pain
procedure
treatment
composition
compound
Prior art date
Application number
NO982582A
Other languages
English (en)
Other versions
NO982582D0 (no
Inventor
Charles H Mitch
Harlan E Shannon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO982582D0 publication Critical patent/NO982582D0/no
Publication of NO982582L publication Critical patent/NO982582L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Processing Of Meat And Fish (AREA)

Abstract

Foreliggende oppfinnelse fremskaffer en fremgangsmåte og en sammensetning for behandling av smerte ved anvendelse av en sammensetning omfattende en azabicyklisk eller tetrahydropyridinforbindelse og en klassisk analgesisk forbindelse.
NO982582A 1995-12-07 1998-06-05 Fremgangsmaate for behandling av smerte NO982582L (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US829595P 1995-12-07 1995-12-07
US830695P 1995-12-07 1995-12-07
US831295P 1995-12-07 1995-12-07
US831395P 1995-12-07 1995-12-07
US831995P 1995-12-07 1995-12-07
US831895P 1995-12-07 1995-12-07
US829895P 1995-12-07 1995-12-07
PCT/US1996/019390 WO1997020556A1 (en) 1995-12-07 1996-12-05 Method for treating pain

Publications (2)

Publication Number Publication Date
NO982582D0 NO982582D0 (no) 1998-06-05
NO982582L true NO982582L (no) 1998-08-03

Family

ID=27567403

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982582A NO982582L (no) 1995-12-07 1998-06-05 Fremgangsmaate for behandling av smerte

Country Status (14)

Country Link
EP (1) EP0866702A4 (no)
JP (1) JP2000501711A (no)
KR (1) KR19990071977A (no)
CN (1) CN1208348A (no)
AU (1) AU715645B2 (no)
CA (1) CA2239732A1 (no)
CZ (1) CZ174598A3 (no)
EA (1) EA199800535A1 (no)
HU (1) HUP0000110A3 (no)
IL (1) IL124786A0 (no)
NO (1) NO982582L (no)
NZ (1) NZ324594A (no)
PL (1) PL327144A1 (no)
WO (1) WO1997020556A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5123200A (en) 1999-06-04 2000-12-28 Eli Lilly And Company 7-oxo-2-azabicyclo(2.2.1)heptanes as selective muscarinic receptor antagonist
CA2919892C (en) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
BR112021016457A2 (pt) * 2019-02-22 2021-10-13 Karuna Therapeutics, Inc. Composto, medicamento e método para tratar dor ou um distúrbio do sistema nervoso central em um paciente que precisa do mesmo
WO2021097427A1 (en) 2019-11-15 2021-05-20 Karuna Therapeutics, Inc. Xanomeline derivatives and methods for treating neurological disorders
WO2023061372A1 (zh) * 2021-10-14 2023-04-20 南京迈诺威医药科技有限公司 占诺美林衍生物的苹果酸盐、a晶型及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5605701A (en) * 1995-02-17 1997-02-25 Eli Lilly And Company Transdermal formulation

Also Published As

Publication number Publication date
KR19990071977A (ko) 1999-09-27
CZ174598A3 (cs) 1999-01-13
CA2239732A1 (en) 1997-06-12
NO982582D0 (no) 1998-06-05
NZ324594A (en) 1999-09-29
EA199800535A1 (ru) 1998-12-24
IL124786A0 (en) 1999-01-26
WO1997020556A1 (en) 1997-06-12
EP0866702A4 (en) 2001-07-25
HUP0000110A2 (hu) 2000-06-28
PL327144A1 (en) 1998-11-23
HUP0000110A3 (en) 2000-09-28
EP0866702A1 (en) 1998-09-30
AU1147697A (en) 1997-06-27
AU715645B2 (en) 2000-02-10
CN1208348A (zh) 1999-02-17
JP2000501711A (ja) 2000-02-15

Similar Documents

Publication Publication Date Title
NO974378D0 (no) Fremgangsmåte til behandling av gasser
NO981810D0 (no) Sammensetninger og fremgangsmÕter for behandling av tilstander ved bensvikt
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
BR9604959A (pt) Composição e método para o tratamento de desensibilização de dentes
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
DE69732152D1 (de) Vorrichtung zur Behandlung von Kopfschmerzen
HUT60138A (en) Process for producing combination compositions suitable for preventing and/or treating benign prostatic hyperplasia
NO963322D0 (no) Fremgangsmåte for behandling av abstinens ved stoffmisbruk
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
AU5729098A (en) Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
MX9401294A (es) Derivados de azolona sustituida
NO982582L (no) Fremgangsmaate for behandling av smerte
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE68917433D1 (de) Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel.
MY115046A (en) Medicinal composition for diabetes
NO306262B1 (no) FremgangsmÕte for hydrogenbehandling
IL119354A0 (en) Method and device for treatment of the brainstem
NO984432L (no) FremgangsmÕte for behandling av migrenesmerte
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
NO982562L (no) Sammensetning for behandling av smerte
DE69412178D1 (de) Apparat zur Behandlung von Lagen
NO990436L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO904873D0 (no) Fremgangsmaate og anordning for behandling av sinkslig.